Identification and validation of biomarkers of IgVH mutation status in chronic lymphocytic leukemia using microfluidics quantitative real-time polymerase chain reaction technology

Journal of Molecular Diagnostics

Volumn 9, Issue 4, 2007, Pages 546-555

  Abruzzo, Lynne V ^a   Barron, Lynn L ^a   Anderson, Keith ^a   Newman, Rachel J ^a   Wierda, William G ^a   O'Brien, Susan ^a   Ferrajoli, Alessandra ^a   Luthra, Madan ^a   Talwalkar, Sameer ^a   Luthra, Rajyalakshmi ^a   Jones, Dan ^a   Keating, Michael J ^a   Coombes, Kevin R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN HEAVY CHAIN;

ACCURACY; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; MICROFLUIDIC ANALYSIS; MODEL; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SEQUENCE ANALYSIS; STUDENT T TEST; VALIDATION PROCESS;

EID: 34548751738     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2007.070001     Document Type: Article

References (45)

1. Rai K, Patel D: Chronic lymphocytic leukemia. Hematology: Basic Principles and Practice. Edited by R Hoffman, E Jr Benz, S Shattil, B Furie, H Cohen, L Silberstein, P McGlave. New York, Churchill Livingstone, 2000
2. Hallek M: New concepts in the pathogenesis, diagnosis, prognostic factors, and clinical presentation of chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000, 4:103-117
3. Keating MJ, O'Brien S: Conventional management of chronic lymphocytic leukemia. Rev Clin Exp Hematol 2000, 4:118-133
4. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999, 94:1848-1854
5. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999, 94:1840-1847
6. Hamblin TJ, Orchard JA, Gardiner A, Oscier DG, Davis Z, Stevenson FK: Immunoglobulin V genes and CD38 expression in CLL. Blood 2000, 95:2455-2457
7. Thunberg U, Johnson A, Roos G, Thorn I, Tobin G, Sallstrom J, Sundstrom C, Rosenquist R: CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood 2001, 97:1892-1894
8. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E: ZAP-70 expression as a surrogate for immunoglobu lin-variable-reg ion mutations in chronic lymphocytic leukemia. N Engl J Med 2003, 348:1764-1775
9. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004, 363:105-111
10. Rosenwald A, Alizadeh AA, Wichopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM: Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia, J Exp Med 2001, 194:1639-1647
11. Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003, 101:4944-4951
12. Admirand JH, Rassidakis GZ, Abruzzo LV, Valbuena JR, Jones D, Medeiros LJ: Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. Mod Pathol 2004, 17:954-961
13. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg IDS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ: ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004, 351:893-901
14. Abruzzo LV, Wang J, Kapoor M, Medeiros LJ, Keating MJ, Edward Highsmith W, Barron LL, Cromwell CC, Coombes KR: Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays. J Mal Diagn 2005, 7:337-345
15. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, Freedman A, Inghirami G, Cro L, Baldini L, Ned A, Califano A, Dalla-Favera. R: Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001, 194:1625-1638
16. Dürig J, Nuckel H, Huttmann A, Kruse E, Halter T, Halfmeyer K, Fuhrer A, Rudolph R, Kalhori N, Nusch A, Deaglio S, Malavasi F, Moroy T, Klein-Hitpass L, Duhrsen U: Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 2003, 101:2748-2755
17. Aalto Y, EI-Rifa W, Vilpo L, Ollila J, Nagy B, Vihinen M, Vilpo J, Knuutila S: Distinct gene expression profiling in chronic lymphocytic leukemia with 11 q23 deletion. Leukemia 2001, 15:1721-1728
18. Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N, Dohner H, Wilgenbus KK: CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001, 91:474-480
19. Abruzzo LV, Lee KY, Fuller A, Silverman A, Keating MJ, Medeiros LJ, Coombes KR: Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data. Biotechniques 2005, 38:785-792
20. McCarthy H, Wierda WG, Barron LL, Cromwell CC, Wang J, Coombes KR, Rangel R, Elenitoba-Johnson KS, Keating MJ, Abruzzo LV: High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood 2003, 101:4903-4908
21. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, Schulman P, Vinciguerra VP, Rai K, Rassenti LZ, Kipps TJ, Dighiero G, Schroeder HW Jr, Ferrarini M, Chiorazzi N: Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998, 102:1515-1525
22. Wang J, Coombes KR, Highsmith WE, Keating MJ, Abruzzo LV: Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics 2004, 20:3166-3178
23. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Bustin SA, Orlando C: Quantitative real-time reverse transcription poiymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 2002, 309:293-300
24. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitaive RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol 2002, 3:RESEARCH0034
25. R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2006
26. Hastie T, Tibshirani R, Friedman J: The Elements of Statistical Learning; Data Mining, Inference, and Prediction. New York, Springer-Verlag, 2001
27. Simon RM, Korn EL, McShane LM, Radmacher MD, Wright GW, Zhao Y: Design and Analysis of DNA Microarray Investigations. New York, Springer-Verlag, 2003
28. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP: Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 2003, 43:1947-1958
29. Paik M, Yang Y: Combining nearest neighbor classifiers versus cross-validation selection. Stat Appl Genet Mal Biol 2004, 3:Article 12
30. Coombes KR, Wang J, Baggerly KA: A statistical method for finding biomarkers from microarray data, with application to prostate cancer. In M.D. Anderson Biostatistics Technical Report UTMDABTR-0007-04, 2004. Houston, TX, The University of Texas M.D. Anderson Cancer Center, 2004
31. Lyons-Weiler J, Patel S, Becich MJ, Godfrey TE: Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics 2004, 5:110
32. Pepe MS, Langton G, Anderson GL, Schummer M: Selecting differentially expressed genes from microarray experiments. Biometrics 2003, 59:133-142
33. Inza I, Larranaga P, Blanco R, Cerrolaza AJ: Filter versus wrapper gene selection approaches in DNA microarray domains. Artif Intell Med 2004, 31:91-103
34. Mälarstig A, Tenno T, Jossan S, Aberg M, Siegbahn A: A quantitative real-time PCR method for tissue factor mRNA. Thromb Res 2003, 112:175-183
35. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N: Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006, 24:3726-3734
36. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxiten-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817-2826
37. Oppezzo P, Vasconcelos Y, Settegrana C, Jeannel D, Vuillier F, Legarff-Tavernier M, Kimura EY, Bechet S, Dumas G, Brissard M, Merle-Beral H, Yamamoto M, Dighiero G, Davi F: The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005, 106:650-657
38. van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ, van Lorn K, Valk PJ: The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. Haematologica 2006, 91:56-63
39. Gauger MA, Sancar A: Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 2005, 65:6828-6834
40. Gorbacheva VY, Kondratov RV, Zhang R, Cherukuri S, Gudkov AV, Takahashi JS, Antoch MP: Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 2005, 102:3407-3412
41. Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T, Yamaguchi K: Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett 1999, 140:227-234
42. Inoue M, Takahashi K, Niide O, Shibata M, Fukuzawa M, Ra C: LDOC1, a novel MZF-1 -interacting protein, induces apoptosis. FEBS Lett 2005, 579:604-608
43. Carroll EA, Gerrelli D, Gasca S, Berg E, Beier DR, Copp AJ, Klingensmith J: Cordon-bleu is a conserved gene involved in neural tube formation. Dev Biol 2003, 262:16-31
44. Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin SH: Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004, 431:1002-1007
45. Zhang W, Mi J, Li N, Sui L, Wan T, Zhang J, Chen T, Cao X: Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6. Biochem Biophys Res Commun 2001, 282:1067-1073